Enhanced local control by radiation boost in breast cancer: Back side of the coin? [9]

Journal of Clinical Oncology

Volumn 25, Issue 36, 2007, Pages 5841-5843

  Bourgier, Céline ^a   Vozenin Brotons, Marie Catherine ^a   Arriagada, Rodrigo ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PENTOXIFYLLINE; PRAVASTATIN; RHO KINASE INHIBITOR; SIMVASTATIN; SUPEROXIDE DISMUTASE;

BREAST CANCER; BREAST FIBROSIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; DRUG EFFICACY; HUMAN; LETTER; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE;

BREAST; BREAST NEOPLASMS; FEMALE; FIBROSIS; HUMANS; QUALITY OF LIFE; RADIOTHERAPY;

EID: 37649014356     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.6035     Document Type: Letter

References (25)

1. Bartelink H, Horiot JC, Poortmans PM, et al: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259-3265, 2007
2. Antonini N, Jones H, Horiot JC, et al: Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 82:265-271, 2007
3. Bartelink H, Horiot JC, Poortmans P, et al: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378-1387, 2001
4. Arriagada R, Mouriesse H, Sarrazin D, et al: Radiotherapy alone in breast cancer: I. Analysis of tumor parameters, tumor dose and local control - The experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 11:1751-1757, 1985
5. Arriagada R, Le MG, Guinebretiere JM, et al: Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14:1617-1622, 2003
6. Strup-Perrot C, Mathe D, Linard C, et al: Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol 287:G875-G885, 2004
7. Denham JW, Hauer-Jensen M: The radiotherapeutic injury: A complex 'wound'. Radiother Oncol 63:129-145, 2002
8. Delanian S, Lefaix JL: Reversibility of radiation-induced fibroatrophy [in French]. Rev Med Interne 23:164-174, 2002
9. Martin M, Lefaix J, Delanian S: TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47:277-290, 2000
10. Bourgier C, Haydont V, Milliat F, et al: Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 54:336-343, 2005
11. Vozenin-Brotons MC, Milliat F, Linard C, et al: Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridization. Radiat Res 161:299-311, 2004
12. Haydont V, Bourgier C, Vozenin-Brotons MC: Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity. Br J Radiol 80:S32-S40, 2007 (Spec No. 1)
13. Haydont V, Mathe D, Bourgier C, et al: Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives. Radiother Oncol 76:219-225, 2005
14. Williams JP, Hernady E, Johnston CJ, et al: Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiat Res 161:560-567, 2004
15. Wang J, Boerma M, Fu Q, et al: Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism. Int J Radiat Oncol Biol Phys 68:1483-1490, 2007
16. Haydont V, Gilliot O, Rivera S, et al: Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection. Int J Radiat Oncol Biol Phys 68:1471-1482, 2007
17. Katz MS, Minsky BD, Saltz LB, et al: Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 62:1363-1370, 2005
18. Haydont V, Bourgier C, Pocard M, et al: Pravastatin inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res 13:5331-5340, 2007
19. Delanian S, Lefaix JL: Current management for late normal tissue injury: Radiation-induced fibrosis and necrosis. Semin Radiat Oncol 17:99-107, 2007
20. Delanian S, Porcher R, Rudant J, et al: Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23:8570-8579, 2005
21. Delanian S, Porcher R, Balla-Mekias S, et al: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21:2545-2550, 2003
22. Okunieff P, Augustine E, Hicks JE, et al: Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol 22:2207-2213, 2004
23. Gothard L, Cornes P, Earl J, et al: Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol 73:133-139, 2004
24. Ozturk B, Egehan I, Atavci S, et al: Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: A double-blind randomized trial. Int J Radiat Oncol Biol Phys 58:213-219, 2004
25. Anscher MS: The irreversibility of radiation-induced fibrosis: Fact or folklore? J Clin Oncol 23:8551-8552, 2005